Teceleukin

N/A

Report date: 2024/12/03 17:47:40

Base Information

Drug NameTeceleukin
Drug Alias NameBioleukin IL-2BioleukinImunaceRo-236019BG-830 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsCarcinoma, Renal CellHemangiosarcoma
Global Approved IndicationsCarcinoma, Renal CellHemangiosarcoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1992/03/27
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesShionogi & Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal CellHemangiosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeL03AC
Related LinksKEGG